Clinical trials
Anticoagulant-induced Bleeding clinical trials
Below are recruiting anticoagulant-induced bleeding clinical trials, each written for real people, not researchers. We’re tracking 4 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04263038RecruitingPhase 4
Watchful waiting versus blood thinners for small lung clots
This trial compares close monitoring (“watch and wait”) versus taking the blood thinner rivaroxaban in people with a small type of lung blood clot. It aims to find out whether low-risk patients can safely avoid or reduce anticoagulation while still staying healthy.
Woluwe-Saint-Lambert, Brussels CapitalAges 18 years+ - NCT05290857Recruiting
Restarting blood thinners after a serious stomach bleed
This study follows people who had a serious, non-surgical stomach/intestine bleed while taking a blood thinner, and looks at when and how they restart a DOAC (a type of blood thinner). It may help your care team reduce the risk of another bleed while still preventing stroke or blood clots.
Calgary, AlbertaAges 18 years+ - NCT06194617Recruiting
Rivaroxaban for older Chinese patients with blood clots in lungs
This trial tests whether a blood thinner called rivaroxaban (a pill) works well for older Chinese patients who have had a blood clot in their lungs and are now on long-term treatment. It aims to see if it's safe and effective for this group.
Beijing, Beijing MunicipalityAges 18 years+ - NCT03244020Enrolling by invitationPhase 4
Aspirin or low-dose blood thinner after bone or leg surgery
This trial compares aspirin versus a low-dose injectable blood thinner (LMWH) to prevent blood clots after certain orthopedic cancer surgeries. It may help lower the risk of dangerous clotting while balancing bleeding and side effects.
Los Angeles, CaliforniaAges 18 years+
Hear when a new Anticoagulant-induced Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for anticoagulant-induced bleeding?
- Yes. Clin2 currently lists 4 recruiting anticoagulant-induced bleeding studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a anticoagulant-induced bleeding trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a anticoagulant-induced bleeding trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.